keyword
https://read.qxmd.com/read/38673415/family-based-treatment-for-anxiety-depression-and-adhd-for-a-parent-and-child
#41
JOURNAL ARTICLE
Rachel Yoder, Alyssa Michaud, Amanda Feagans, Kendra E Hinton-Froese, Allison Meyer, Victoria A Powers, Leah Stalnaker, Melissa K Hord
Children with mental illness commonly live with caregivers who suffer from mental illness. Integrated mental-health-treatment approaches can provide more convenient and comprehensive care for families. This case report describes family-based treatment (FBT) for one parent/child dyad. The parent was a 37-year-old female with a history of anxiety and major depressive disorder and concern for symptoms of attention-deficit/hyperactivity disorder (ADHD). The child was an 8-year-old female with generalized anxiety disorder and concern for ADHD and behavioral problems...
April 19, 2024: International Journal of Environmental Research and Public Health
https://read.qxmd.com/read/38673391/the-social-context-of-pregnancy-respectful-maternity-care-biomarkers-of-weathering-and-postpartum-mental-health-inequities-a-scoping-review
#42
REVIEW
Bridget Basile-Ibrahim, Joan Combellick, Thomas L Mead, Alee Sorensen, Janene Batten, Robyn Schafer
Background: Mental health disorders are the number one cause of maternal mortality and a significant maternal morbidity. This scoping review sought to understand the associations between social context and experiences during pregnancy and birth, biological indicators of stress and weathering, and perinatal mood and anxiety disorders (PMADs). Methods: A scoping review was performed using PRISMA-ScR guidance and JBI scoping review methodology. The search was conducted in OVID Medline and Embase. Results: This review identified 74 eligible English-language peer-reviewed original research articles...
April 15, 2024: International Journal of Environmental Research and Public Health
https://read.qxmd.com/read/38672750/curcumin-as-a-multifunctional-spice-ingredient-against-mental-disorders-in-humans-current-clinical-studies-and-bioavailability-concerns
#43
REVIEW
Maria Spanoudaki, Sousana K Papadopoulou, Georgios Antasouras, Konstantinos A Papadopoulos, Evmorfia Psara, Theofanis Vorvolakos, Evangelos Solovos, Maria Chrysafi, Michalis Psallas, Maria Mentzelou, Despoina Ourda, Constantinos Giaginis
BACKGROUND: Mental disorders in terms of depression, anxiety, and stress are one of the major causes of burden globally. Over the last two decades, the use of plant-based substances in the treatment of mental disorders in combination or not with medication has increasingly attracted the interest of the scientific research community. However, even if there is a plethora of naturally occurring bioactive compounds, most of them have low bioavailability, rendering them unable to insert into the bloodstream to exert their biological activities...
April 5, 2024: Life
https://read.qxmd.com/read/38672042/psychiatric-co-morbidities-and-profile-of-patients-with-irritable-bowel-syndrome-in-northern-india
#44
JOURNAL ARTICLE
Ankita Saroj, Adarsh Tripathi, Sumit Rungta, Sujita Kumar Kar
OBJECTIVES: To study sociodemographic and clinical variables, including psychiatric co-morbidities, in patients with irritable bowel syndrome. METHODS: A total of 158 patients attending a medical gastroenterology clinic in a tertiary care center in Northern India were screened, from whom 100 were selected for the study. Rome IV criteria were used to diagnose IBS, and the severity of symptoms was assessed by the Irritable Bowel Syndrome Symptom Severity Scale (IBS-SSS)...
April 18, 2024: Brain Sciences
https://read.qxmd.com/read/38671964/development-and-validation-of-a-food-frequency-questionnaire-for-evaluating-the-nutritional-status-of-patients-with-serious-mental-illnesses-dietq-smi-in-bahrain
#45
JOURNAL ARTICLE
Haitham Jahrami, Zahra Saif, Achraf Ammar, Waqar Husain, Khaled Trabelsi, Hadeel Ghazzawi, Seithikurippu R Pandi-Perumal, Mary V Seeman
General food frequency questionnaires (FFQs) have not been tailored for or validated in individuals with psychiatric disorders. Given the unique eating behaviors of patients with serious mental illnesses (SMIs), custom-made tools are needed. Therefore, we developed and validated an FFQ customized to individuals with SMIs. A total of 150 adults with SMIs (schizophrenia, bipolar disorder, or major depression) were recruited from Bahrain. The participants completed the 50-item Dietary Intake Evaluation Questionnaire for Serious Mental Illness (DIETQ-SMI) FFQ and a 3-day food record (FR)...
March 26, 2024: Brain Sciences
https://read.qxmd.com/read/38671846/the-association-of-redox-regulatory-drug-target-genes-with-psychiatric-disorders-a-mendelian-randomization-study
#46
JOURNAL ARTICLE
Zhe Lu, Yang Yang, Guorui Zhao, Yuyanan Zhang, Yaoyao Sun, Yundan Liao, Zhewei Kang, Xiaoyang Feng, Junyuan Sun, Weihua Yue
Redox regulatory drug (RRD) targets may be considered potential novel drug targets of psychosis due to the fact that the brain is highly susceptible to oxidative stress imbalance. The aim of the present study is to identify potential associations between RRD targets' perturbation and the risk of psychoses; to achieve this, Mendelian randomization analyses were conducted. The expression quantitative trait loci (eQTL) and protein QTL data were used to derive the genetic instrumental variables. We obtained the latest summary data of genome-wide association studies on seven psychoses as outcomes, including schizophrenia (SCZ), bipolar disorder (BD), major depressive disorder (MDD), attention-deficit/hyperactivity disorder, autism, obsessive-compulsive disorder and anorexia nervosa...
March 27, 2024: Antioxidants (Basel, Switzerland)
https://read.qxmd.com/read/38671560/a-systematic-review-and-meta-analysis-of-the-preclinical-and-clinical-results-of-low-field-magnetic-stimulation-in-cognitive-disorders
#47
REVIEW
Nicholas Mellon, Brett Robbins, Rebekah van Bruggen, Yanbo Zhang
Cognitive disorders such as major depressive disorder and bipolar disorder severely compromise brain function and neuronal activity. Treatments to restore cognitive abilities can have severe side effects due to their intense and excitatory nature, in addition to the fact that they are expensive and invasive. Low-field magnetic stimulation (LFMS) is a novel non-invasive proposed treatment for cognitive disorders. It repairs issues in the brain by altering deep cortical areas with treatments of low-intensity magnetic stimulation...
April 29, 2024: Reviews in the Neurosciences
https://read.qxmd.com/read/38671298/long-term-health-related-quality-of-life-and-mental-health-in-patients-with-immune-thrombotic-thrombocytopenic-purpura
#48
JOURNAL ARTICLE
Olga Mulas, Fabio Efficace, Alessandro Costa, Thomas Baldi, Filippo Zerbini, Daniela Mantovani, Emanuela Morelli, Daniela Perra, Giorgio La Nasa, Giovanni Caocci
Immune thrombotic thrombocytopenic purpura (iTTP) is a rare and potentially life-threatening disorder. Treatment advances have lowered morbidity rates, but past acute events can still cause long-term consequences, reducing health-related quality of life (HRQoL) and determining cognitive impairment, anxiety, and depression. We aimed to investigate these aspects and the role of caplacizumab and rituximab: 39 patients were evaluated using the Medical Outcomes Study 36-Item Short Form Health Survey (SF-36), the FACIT-Fatigue, the Hospital Anxiety and Depression Scale, and the Functional Assessment in Cancer Therapy-Cognitive Function questionnaires...
April 27, 2024: Annals of Hematology
https://read.qxmd.com/read/38670824/psychiatric-disorders-in-pregnant-women-admitted-to-the-high-risk-obstetric-service-in-a-colombian-university-clinic-between-2013-and-2017
#49
JOURNAL ARTICLE
Gustavo A Constaín, María Victoria Ocampo Saldarriaga, José Gabriel Franco Franco Vásquez, Luisa Fernanda Naranjo, Cristóbal Restrepo Conde, Daniel Estrada Muñoz, Laura Chaverra López, Jerónimo Buriticá Buriticá González
OBJECTIVE: To determine the psychiatric diagnoses and treatments of patients admitted to the high-risk obstetric service who underwent a consultation with a liaison psychiatrist. METHODS: A descriptive observational study that included pregnant women from the high-risk obstetric service of a highly specialised clinic in Medellín, who had a liaison psychiatry consultation between 2013 and 2017. The main variables of interest were psychiatric and obstetric diagnoses and treatments, in addition to biopsychosocial risk factors...
April 25, 2024: Revista Colombiana de psiquiatría (English ed.)
https://read.qxmd.com/read/38670606/screening-for-those-at-risk-for-anxiety-and-depression-warranting-further-clinical-evaluation-among-patients-presenting-to-breast-services-a-single-centre-cross-sectional-study
#50
JOURNAL ARTICLE
Sakina Husain, Shilpa Rao, Sridhar Suresh, Kevin Victor Albert Jesudoss, Balamurali Krishna, Jeffrey Pradeep Raj
OBJECTIVES: Studies show that anxiety and depression are widespread across patients presenting to outpatient services for medical illnesses. We expect similar or even higher prevalence in patients with breast complaints owing to the relevance of breasts in terms of sexuality, identity and confidence. Thus, this study was proposed to estimate the prevalence and identify risk factors for being at risk for anxiety and depression in patients seeking breast services. DESIGN: Descriptive, cross-sectional study...
April 25, 2024: BMJ Open
https://read.qxmd.com/read/38669833/inverse-association-between-slow-wave-sleep-and-low-grade-inflammation-in-children-and-adolescents-with-major-depressive-disorder
#51
JOURNAL ARTICLE
Michael A Strumberger, Isabelle Häberling, Sophie Emery, Mona Albermann, Noemi Baumgartner, Catrina Pedrett, Salome Wild, Brigitte Contin-Waldvogel, Susanne Walitza, Gregor Berger, Klaus Schmeck, Christian Cajochen
OBJECTIVE: To investigate the relationship between both self-reported and objective sleep variables and low-grade inflammation in children and adolescents with major depressive disorder (MDD) of moderate to severe symptom severity. METHODS: In this cross-sectional study, we examined twenty-nine children and adolescents diagnosed with MDD and twenty-nine healthy controls (HC). Following a one-week actigraphy assessment, comprehensive sleep evaluations were conducted, including a one-night sleep EEG measurement and self-reported sleep data...
April 15, 2024: Sleep Medicine
https://read.qxmd.com/read/38669232/efficacy-and-safety-of-aripiprazole-or-bupropion-augmentation-and-switching-in-patients-with-treatment-resistant-depression-or-major-depressive-disorder-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials
#52
JOURNAL ARTICLE
Mengjia Ji, Junfei Feng, Guirong Liu
OBJECTIVES: To report the first and largest systematic review and meta-analysis of randomized controlled trials (RCT) to evaluate the efficacy and safety of aripiprazole or bupropion augmentation and switching in patients with treatment-resistant depression (TRD) or major depressive disorder(MDD). METHODS: We conducted a systematic literature retrieval via PubMed, Embase, Web of Science, and Cochrane until April 2023 for RCT, which evaluated the efficacy and safety of aripiprazole or bupropion augmentation and switching for patients with TRD or MDD...
2024: PloS One
https://read.qxmd.com/read/38668616/botulinum-toxin-injections-for-psychiatric-disorders-a-systematic-review-of-the-clinical-trial-landscape
#53
REVIEW
Ilya Demchenko, Alyssa Swiderski, Helen Liu, Hyejung Jung, Wendy Lou, Venkat Bhat
Botulinum toxin type A (BONT-A) has shown promise in improving the mood-related symptoms of psychiatric disorders by targeting muscles linked to the expression of negative emotions. We conducted a systematic review of past and ongoing efficacy trials of BONT-A therapy for psychiatric disorders to identify relevant trends in the field and discuss the refinement of therapeutic techniques. A comprehensive search for published clinical trials using BONT-A injections for psychiatric disorders was performed on 4 May 2023 through OVID databases (MEDLINE, Embase, APA PsycINFO)...
April 15, 2024: Toxins
https://read.qxmd.com/read/38667636/nanogels-based-on-n-n-dimethylacrylamide-and-%C3%AE-cyclodextrin-triacrylate-for-enhanced-solubility-and-therapeutic-efficacy-of-aripiprazole
#54
JOURNAL ARTICLE
Siyka Stoilova, Dilyana Georgieva, Rositsa Mihaylova, Petar D Petrov, Bistra Kostova
Aripiprazole (ARZ) is a medication used for the treatment of various diseases such as schizophrenia, bipolar disorder, major depressive disorder, autism, and Tourette's syndrome. Despite its therapeutic benefits, ARZ is characterized by a poor water solubility which provoked the development of various delivery systems in order to enhance its solubility. In the present work, a nanoscale drug delivery system based on N,N-dimethylacrylamide (DMAA) and β-cyclodextrin triacrylate (β-CD-Ac3 ) as potential aripiprazole delivery vehicles was developed...
March 22, 2024: Gels
https://read.qxmd.com/read/38666648/effects-of-chronic-pain-diagnoses-on-the-antidepressant-efficacy-of-transcranial-magnetic-stimulation
#55
JOURNAL ARTICLE
Houtan Totonchi Afshar, Joel N Fishbein, Erica J Martinez, Gage M Chu, Mohammad A Shenasa, Dhakshin Ramanathan, Matthew S Herbert
OBJECTIVE: Major depressive disorder (MDD) and chronic pain are highly comorbid and bidirectionally related. Repetitive transcranial magnetic stimulation (rTMS) over the dorsolateral prefrontal cortex is effective in treating MDD, but additional research is needed to determine if chronic pain interferes with rTMS for MDD. METHODS: Participants were 124 veterans (Mage = 49.14, SD = 13.83) scheduled for 30 sessions of rTMS across six weeks. Depression severity was monitored weekly using the Patient Health Questionnaire-9...
April 26, 2024: Psychosomatic Medicine
https://read.qxmd.com/read/38666138/the-role-of-cortical-midline-structure-in-diagnoses-and-neuromodulation-for-major-depressive-disorder
#56
JOURNAL ARTICLE
Xinyuan Yan
No abstract text is available yet for this article.
2024: Psychoradiology
https://read.qxmd.com/read/38665940/effect-of-novel-accelerated-intermittent-theta-burst-stimulation-on-suicidal-ideation-in-adolescent-patients-with-major-depressive-episode-a-randomised-clinical-trial
#57
JOURNAL ARTICLE
Dong Huang, Shuming Zhong, Xiaodong Song, Rongxu Zhang, Shunkai Lai, Yanbin Jia
No abstract text is available yet for this article.
2024: General Psychiatry
https://read.qxmd.com/read/38665721/micrornas-as-diagnostic-biomarkers-and-predictors-of-antidepressant-response-in-major-depressive-disorder-a-systematic-review
#58
REVIEW
Beatriz A Carneiro, Lívia N Franco Guerreiro-Costa, Daniel Lins-Silva, Daniela Faria Guimaraes, Lucca S Souza, Gustavo C Leal, Ana Teresa Caliman-Fontes, Graziele Beanes, Ryan Dos S Costa, Lucas C Quarantini
Despite the hardships of major depressive disorder (MDD), biomarkers for the diagnosis and pharmacological management of this condition are lacking. MicroRNAs are epigenetic mechanisms that could provide promising MDD biomarkers. Our aim was to summarize the findings and provide validation for the selection and use of specific microRNAs as biomarkers in the diagnosis and treatment of MDD. A systematic review was conducted using the PubMed/Medline, Cochrane, PsycINFO, Embase, and LILACS databases from March 2022 to November 2023, with clusters of terms based on "microRNA" and "antidepressant"...
March 2024: Curēus
https://read.qxmd.com/read/38665705/analyzing-the-prevalence-of-depression-and-anxiety-symptoms-among-relatives-of-cancer-patients-in-kuwait
#59
JOURNAL ARTICLE
Layal Alqaysi, Ahmad F Alenezi, Khaled Malallah, Ebrahim Alsabea, Mona Khalfan, Anwar Alnouri, Haitham Jahrami
INTRODUCTION: The mental health impact on relatives of cancer patients frequently goes unnoticed and is commonly undervalued. This study aimed to explore how personal factors such as the patient's degree of kin, marital status, cancer stage, and number of diagnosed family members are correlated with the severity of depression and anxiety among relatives of cancer patients. METHOD: This self-administered cross-sectional survey was conducted in Kuwait, employing a random sampling method to recruit participants...
March 2024: Curēus
https://read.qxmd.com/read/38665322/the-significance-of-disease-knowledge-as-a-risk-factor-for-depression-and-anxiety-in-diabetic-patients
#60
JOURNAL ARTICLE
Nora Labeeb El-Tantawy, Amirah Kodran AlZhrany, Hibah Saeed ALZahrani, Rimas Saeed ALZahrani, Waad Khader Al Zahrani, Ali Saleh ALGhamdi, Rabab Morsy Abouhussien, Hind Ali Alzahrani, Mohammed Adel Shanawaz
BACKGROUND: Diabetes mellitus is a chronic disease that can lead to depression and anxiety disorders if it is not controlled and managed properly. This study aimed to estimate the prevalence of depression and anxiety disorders among diabetic patients and to determine whether patient knowledge is a risk factor. METHODS: The study included 220 patients with diabetes who attended the Diabetic Care Center. Socio-demographic data on the patients was collected. The Hospital Anxiety and Depression Scale questionnaire was used to assess patients' depression and anxiety levels...
February 29, 2024: Journal of Lifestyle Medicine
keyword
keyword
5557
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.